Health Care & Life Sciences » Pharmaceuticals | Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
2,200.10
2,911.60
6,211.30
16,720.10
25,485.70
SG&A Expense
8,452.50
14,088.20
10,344.40
9,879.50
13,249.00
EBIT
6,289.90
11,203.20
4,158.60
6,787.50
12,192.10
Non Operating Income/Expense
25.50
34.30
187.50
17.10
485.70
Pretax Income
5,988.90
10,820.50
3,762.80
7,069.00
12,942.30
Income Tax
463.00
406.10
609.10
45.30
281.90
Consolidated Net Income
5,525.90
10,414.40
3,153.70
7,114.30
13,224.20
Net Income
5,525.90
10,414.40
3,121.20
7,180.80
13,224.20
Net Income After Extraordinaries
5,525.90
10,414.40
3,121.20
7,180.80
13,224.20
Net Income Available to Common
5,525.90
10,414.40
3,121.20
7,180.80
13,224.20
EPS (Basic)
0.14
0.24
0.07
0.15
0.28
Basic Shares Outstanding
38,697.40
43,373.70
45,286.30
47,670.20
47,742.80
EPS (Diluted)
0.14
0.24
0.07
0.14
0.27
Diluted Shares Outstanding
38,697.40
43,373.70
45,286.30
49,626.80
49,590.60
EBITDA
6,252.50
11,176.60
4,133.10
6,840.70
12,236.70
Non-Operating Interest Income
326.50
348.40
208.40
264.40
264.50
Minority Interest Expense
-
-
32.50
66.50
-

About Clinuvel Pharmaceuticals

View Profile
Address
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.clinuvel.com
Updated 07/08/2019
Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.